Three-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type b (Hib)-Neisseria meningitidis Serogroup C-tetanus Toxoid Conjugate Vaccine in Hib-primed Toddlers

Citation

Booy, R, Richmond, P, Nolan, T et al 2013, 'Three-year Antibody Persistence and Safety After a Single Dose of Combined Haemophilus influenzae Type b (Hib)-Neisseria meningitidis Serogroup C-tetanus Toxoid Conjugate Vaccine in Hib-primed Toddlers', The Pediatric Infectious Disease Journal, vol. 32, no. 2, pp. 169-174.

Year

2013

Field of Research

  • Paediatrics

Updated:  19 May 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers